Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Merck & Co Inc.
WARNING LETTER
•Merck & Co Inc.

Merck & Co Inc. – FDA Warning Letter

Record Details

The FDA's Center for Veterinary Medicine (CVM) issued a Warning Letter to Merck & Co., Inc., regarding its subsidiary Intervet Inc.'s failure to submit required Three-Day NADA/ANADA Field Alert Reports (FARs) for Vetsulin (porcine insulin zinc suspension), NADA 141-236. Intervet Inc. violated 21 CFR 514.80(b)(1) by not reporting product and manufacturing defects that could lead to serious adverse drug events within three working days of discovery.

Specifically, Intervet Inc.'s analytical testing revealed that several Vetsulin batches (b)(4) and (b)(4) did not meet stability specifications for non-extractable insulin before their expiration dates. Such out-of-specification results for insulin products can lead to serious adverse drug events and are subject to FAR requirements. Despite being aware of these out-of-specification results, Intervet Inc. failed to submit the required FARs. This failure constitutes a prohibited act under section 301(e) of the Act, 21 USC 331(e).

Merck & Co., Inc. is responsible for investigating and correcting these violations and preventing recurrence. Failure to promptly correct these issues may result in legal action, including seizure and injunction, and may impact eligibility for federal contracts. A written response detailing corrective actions, including documentation and a timeline for completion, is required within

Company
Merck & Co Inc.
Product type
Veterinary
Office
Center for Veterinary Medicine
People
  • Neal Bataller (Division Director)
  • Jonathan Bray
View Company Profile

ID · 197e46f0-2b2c-43c9-8146-9f733c6c79d5

Violation Codes3
21 CFR 514.8021 CFR 514.80(b)(1)21 U.S.C. 331(e)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Merck & Co Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.